Dr. Klein-Schwartz has extensively published and presented about her areas of toxicology expertise. Some selected publications and presentations are listed below.

Selected Publications

Dougherty P*, Klein-Schwartz W. Octreotide’s role in the management of sulfonylurea-induced hypoglycemia. Journal of Medical Toxicology, 2010 (Jun);6(2):199-206.

Klein-Schwartz W, Doyon S, Dowling T. Evaluation of a novel charcoal cookie formulation for drug adsorption. Pharmacotherapy, 2010;30(9):888-894.

Klein-Schwartz W, Sorkin J, Doyon S. Impact of voluntary withdrawal of over-the counter cough and cold medications on pediatric ingestions reported to poison centers. Pharmacoepidemiology and Drug Safety, 2010 (Aug);19(8):819-24.

Anderson B, Ke X, Klein-Schwartz W. Potential for erroneous interpretation of poisoning outcomes due to changes in National Poison Data System Reporting. Clinical Toxicology, 2010;48(7):745-9.

Benson BE, Farooqi MF, Klein-Schwartz W, Litovitz T, Webb AN, Borys DJ, Lung D, Rose SR, Aleguas A, Sollee DR, Seifert SA. Diphenhydramine dose-response: A novel approach to determine triage thresholds. Clinical Toxicology, 2010;48(8):820-831.

Klein-Schwartz W, Doyon S. Intravenous acetylcysteine for the treatment of acetaminophen overdose. Expert Opinion in Pharmacotherapy; 2011;12(1):119-130.

Dougherty PP, Klein-Schwartz W. Unexpected late rise in plasma acetaminophen concentrations in acute acetaminophen overdose. The Journal of Emergency Medicine; 2012:43:58-63.

Klein-Schwartz W, Benson BE, Lee SC*, Litovitz T. Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children. Clinical Toxicology; 2012:50:418-23.

Doyon S, Tra Y, Klein-Schwartz W. Decrease in therapeutic errors involving prescription cough and cold medications in young children. Journal of Pediatric Pharmacology and Therapeutics; 2012;17:84-7.

Doyon S, Klein-Schwartz 1, Anderson BA, Welsh C. A novel approach to informing the public about the risks of overdose and nonmedical use of prescription medications. American Journal of Addictions; 2013;22:108-112.

Dougherty PP, Lee SC, Lung D, Klein-Schwartz W. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children. Pediatric Emergency Care 2013;29(3):292-5.

Lee SC, Klein-Schwartz W, Welsh C, Doyon S. Medical outcomes associated with nonmedical use of methadone and buprenorphine. Journal of Emergency Medicine 2013 May 10 [Epub ahead of print]

 Selected Book Chapters:

Klein-Schwartz W. Clinical Toxicology, In Helms RA, Quan DJ, Herfindal ET, Gourley DR (editors). Textbook of Therapeutics: Drug and Disease Management, 8th edition, Philadelphia: Lippincott Williams & Wilkins, 2006, 73-90.

Klein-Schwartz W. Toxicologic issues in the geriatric patient. In Shannon MW, Borron SW, Burns MJ: Clinical Management of Poisoning and Drug Overdose, 4th edition, Philadelphia: Saunders Elsevier, 2007;377-382.

Klein-Schwartz W, Crouch BI. Poisoning. In: Handbook of Nonprescription Drugs, Krinsky DL, Berardi RR, Ferreri SP, Hume AL, et al (editors), 17th edition, Washington: American Pharmaceutical Association, 2012, 341-352.

 Selected Posters/Platform Presentations

Klein-Schwartz W, Doyon S, Dowling T. Evaluation of a novel charcoal cookie formulation for drug adsorption. American College of Clinical Pharmacy Spring Practice and Research Forum, Charlotte, NC, April 26, 2010.

Medication errors associated with intravenous acetylcysteine. Joint American-Israeli Medical Toxicology Conference. Haifa, Israel, November 16, 2010.

Klein-Schwartz W, Benson B, Litovitz T, Lee S. Comparison of citalopram and other selective serotonin reuptake inhibitors (SSRI) overdoses in children. North American Congress of Clinical Toxicology, Washington, DC, September 24, 2011.

Dougherty PP, Lung D, Lee S, Klein-Schwartz W. Comparison of octreotide and dextrose only for treatment of sulfonylurea overdose in children. North American Congress of Clinical Toxicology, Washington, DC, September 24, 2011.

Lee SC, Doyon S, Klein-Schwartz W. Comparison of toxicity of nonmedical use of buprenorphine and methadone. North American Congress of Clinical Toxicology, Washington, DC, September 24, 2011.

Klein-Schwartz W, Gonzales L, Lee SC, Doyon S. Comparison of toxicity from exposures to buprenorphine or methadone with and without benzodiazepines. European Association of Poison Control Centres and Clinical Toxicologists, London, June 1, 2012.

Anderson BD, Schwartz EK, Tra Y, Klein-Schwartz W. Atypical antipsychotic exposures in young children. North American Congress of Clinical Toxicology, Las Vegas, October 3, 2012.

Lee SC, Klein-Schwartz W, Beuhler MC. Doyon S. Fatalities from acetaminophen combination products reported to poison centers. North American Congress of Clinical Toxicology, Las Vegas, October 4, 2012.

Lee SC, Klein-Schwartz W, Gonzales L, Doyon S. Comparison of concurrent nonmedical use of benzodiazepines and methadone or buprenorphine. North American Congress of Clinical Toxicology, Las Vegas, October 4, 2012.

Anderson BD, Schwartz EK, Tra Y, Klein-Schwartz W. Review of intentional abuse of quetiapine exposures. North American Congress of Clinical Toxicology, Las Vegas, October 6, 2012.

Klein-Schwartz W. Nonmedical use of buprenorphine and methadone: Comparison of toxicity with and without benzodiazepines. Joint American-Israeli Medical Toxicology Conference. Haifa, Israel, April 25, 2013.

Klein-Schwartz W, Gonzales L, Anderson BD. Evaluation of questiapine abuse and misuse reported to poison centers. European Association of Poison Control Centres and Clinical Toxicologists, Copenhagen, Denmark, May 30, 2013.